Vyndaqel
NDC 0069-1975, tafamidis meglumine, capsule, liquid filled, from Pfizer Laboratories Div Pfizer Inc.
- Product NDC
- 0069-1975
- Status
- Listed
- Labeler
- Pfizer Laboratories Div Pfizer Inc
- Dosage form
- CAPSULE, LIQUID FILLED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA211996
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0069-1975 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TAFAMIDIS MEGLUMINE20 mg/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0069-1975-40 | 00069197540 | 4 CARTON in 1 CARTON (0069-1975-40) / 30 BLISTER PACK in 1 CARTON / 1 CAPSULE, LIQUID FILLED in 1 BLISTER PACK (0069-1975-12) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/1b4121ee-a733-4456-a917-be2603477839
Use it
Look up 0069-1975 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0069-1975 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0069-1975. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.